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Phosphoinositides (PIPs) are ubiquitous regulators of signal transduction events in eukaryotic cells. PIPs are degraded by
various enzymes, including PIP phosphatases. The integral membrane Sac1 phosphatases represent a major class of such
enzymes. The central role of lipid phosphatases in regulating PIP homeostasis notwithstanding, the biological functions
of Sac1-phosphatases remain poorly characterized. Herein, we demonstrate that functional ablation of the single murine
Sac1 results in preimplantation lethality in the mouse and that Sac1 insufficiencies result in disorganization of mamma-
lian Golgi membranes and mitotic defects characterized by multiple mechanically active spindles. Complementation
experiments demonstrate mutant mammalian Sac1 proteins individually defective in either phosphoinositide phospha-
tase activity, or in recycling of the enzyme from the Golgi system back to the endoplasmic reticulum, are nonfunctional
proteins in vivo. The data indicate Sac1 executes an essential household function in mammals that involves organization
of both Golgi membranes and mitotic spindles and that both enzymatic activity and endoplasmic reticulum localization
are important Sac1 functional properties.
INTRODUCTION
Spatial and temporal regulation of intracellular signaling in
eukaryotic cells involves the compartmentalization of mem-
brane surfaces into discrete, albeit often transient, functional
units. There are several biochemical strategies by which cells
generate such units or domains. One well-established strat-
egy uses the chemical diversity offered by phosphoinositides
(PIPs), i.e., phosphorylated forms of phosphatidylinositol
(PtdIns) (Majerus, 1997; Fruman et al., 1998; Strahl and Thor-
ner, 2007). The chemical heterogeneity of individual PIP
species permits the construction of chemically unique plat-
forms on membrane surfaces that, in turn, recruit unique
cohorts of proteins that drive specific biological reactions.
Spatial and temporal control of such reactions requires a
finely coordinated balance between the activities of the lipid
kinases that produce PIPs and the activities of enzymes that
degrade them. PIP turnover is catalyzed by two general
classes of enzymes: phospholipases and PIP phosphatases.
Although experimental scrutiny of the phospholipases has
historically been more intense, recent demonstrations of the
significant biological functions played by PTEN, the myotu-
bularins, and synaptojanins highlight the general impor-
tance of PIP phosphatases (Wishart et al., 2001; Wishart and
Dixon, 2002; Wenk and De Camilli, 2004).
The SAC domain derives from the yeast Sac1 protein
(ySac1; Cleves et al., 1989), and it represents a signature for
PIP phosphatase catalytic activity (Guo et al., 1999). PIP
phosphatases such as phosphatase and tensin homolog (mu-
tated in multiple advanced cancers 1) (PTEN) (Maehama et
al., 2001), synaptojanins (Cremona et al., 1999), and synap-
tojanin-like proteins (Srinivasan et al., 1997; Stolz et al., 1998)
all harbor SAC domains. The prototypical member of this
family, ySac1, catalyzes the dephosphorylation of PIPs with
the intriguing exception that PtdIns-4,5-P2 is not a substrate
(Guo et al., 1999; Rivas et al., 1999; Hughes et al., 2000). In
keeping with the multiplicity of PIP signaling functions in
eukaryotes, Sac1 loss-of-function (LOF) elicits pleitotropic
effects in yeast that reflect broad-ranging alterations in mul-
tiple aspects of lipid metabolism (Cleves et al., 1989; Novick
et al., 1989; Rivas et al., 1999; Tahirovic et al., 2005). Such
metabolic alterations contribute to mislocalization of PIP
binding proteins from the Golgi complex to inappropriate
compartments (Li et al., 2002). ySac1 is an unusual PIP
phosphatase in several respects. First, ySac1 degrades a Pt-
dIns-4-P pool produced by the Stt4 PtdIns 4-OH kinase, one
of three PtdIns 4-OH kinases in this organism (Nemoto et al.,
2000; Foti et al., 2001). Second, ySac1 is an integral membrane
protein of endoplasmic reticulum (ER) and Golgi mem-
branes (Cleves et al., 1989; Whitters et al., 1993; Nemoto et al.,
2000). This disposition is determined by two C-terminal
membrane anchor sequences with the large catalytic domain
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oriented toward the cytosolic face (Konrad et al., 2002; Sup-
plemental Figure S1A). Finally, ER residence of ySac1 as an
integral protein is key to ySac1 function in vivo (Rivas et al.,
1999).
ySac1 homologues are conserved throughout the Eu-
karyota (Supplemental Figure S1B). Mammalian Sac1 is an
integral membrane protein with an anchor-sequence ar-
rangement similar to that of ySac1p (Supplemental Figure
S1, A and B), and it primarily resides in ER membranes
(Nemoto et al., 2000). ER retention of the mammalian en-
zyme is controlled by a COP1-Sac1 binding interaction that
captures enzyme in the Golgi system and recycles it back to
the ER in COP1 vesicles (Rohde et al., 2003). Herein, we
report the consequences of loss of Sac1 function in mice and
in human cell models. Sac1 nullizygosity results in preim-
plantation lethality in mice, and reduced hSac1 expression is
deleterious to cell viability of human cell lines. From a
subcellular perspective, specific derangements of Golgi
membrane and mechanically active mitotic spindle organi-
zation are recorded in hSac1-depleted cells. Although cargo
transport to, through, and from the disorganized Golgi sys-
tem is not impaired, hSac1-depleted cells arrest in mitosis.
The Golgi and mitotic spindle phenotypes are rescued by
expression of silencing-resistant murine Sac 1 (mSac1), but
not by “catalytic-dead” mSac1 or by mSac1 forms incompe-
tent for COP1 binding. We conclude that mammalian Sac1
PIP phosphatases execute essential housekeeping functions
required for proper Golgi and mitotic spindle organization
and that both PIP phosphatase activity and COP1-depen-
dent retrograde trafficking are functionally important prop-
erties of these enzymes.
MATERIALS AND METHODS
Bioinformatic Methods
Sequences were analyzed by BLAST (http://www.ncbi.nlm.nih.gov/
BLAST/). Sequence alignments were generated by the MegAlign 5.05 pro-
gram.
Media and Genetic Techniques
Lithium acetate yeast transformation and genetic techniques were performed,
and yeast media were prepared as described previously (Kearns et al., 1997;
Xie et al., 1998; Guo et al., 1999; Phillips et al., 1999). Yeast strains used in
this study included: CTY182 (MATa ura3-52 lys2-801 his3-200), CTY244
(CTY182 sac11-354::HIS3) (Cleves et al., 1991; Phillips et al., 1999).
Site-directed Mutagenesis
Site-directed mutagenesis of murine SAC1 was performed as described pre-
viously (Nemoto et al., 2000). Mutagenic primers were as follows: for
msac1D391N, 5-CGCAGCA ACTGCATGAATTGTCTAGACAG-3 and 5-CT-
GTCTAGACAATTCATGCAGTTGCTGCG-3; for msac1A442V, 5-CCTGGGC-
CGATAATGTTAATGCTTGTGCC-3 and 5-GGCACAAGCATTAACA
TTATCGGCCCAGG-3; and for msac1R480H, 5-GGCTTCAACTCATTATTA-
CACTATTACAAGAACA AC-3 and 5-GTTGTTCTTGTAATAGTGTAATA-
ATGAGTTGAAGCC-3. Fidelity of mutagenesis was confirmed by DNA
sequence analysis. The point mutant msac1 and wild-type mSAC1 cDNAs
were individually subcloned into a derivative of the yeast URA3 episomal
vector YEplac195, which is engineered to express genes of interest in yeast
from the constitutive SEC14 promoter.
Inositol Radiolabeling and PIP Analyses
PIPs were identified and quantified as described previously (Guo et al., 1999;
Rivas et al., 1999; Nemoto et al., 2000). To analyze PIPs in mammalian cells,
control and hSAC1 small interfering RNA (siRNA)-treated HeLa cells were
cultured in six-well plates, and radiolabeled to steady state with 100 Ci/ml
[3H]inositol (Ins) for 48 h. Cells were scraped, phospholipids (PLs) were
extracted and deacylated with methylamine, and soluble glycerophosphoi-
nositol species were resolved and quantified as described previously (Guo et
al., 1999; Rivas et al., 1999; Nemoto et al., 2000; Alb et al., 2002).
Characterization of the msac1::-GEO Splice-Trap Allele
To examine SAC1 function in mice, we characterized a Bay Genomics embry-
onic stem (ES) cell line with a pGT1dTM splice-trap insertion annotated to
reside in the first intron of the mSAC1 gene (Figure 1A). The gene-trap
contains a splice-acceptor sequence positioned upstream of a -GEO reporter
(-galactosidase::neomycin phosphotransferase gene fusion). Gene trap inser-
tion is expected to divert normal mSAC1 splicing such that the first exon is
fused to an otherwise promoter-less -GEO gene. To confirm annotation of
the splice-trap insertion site within the 12.4-kb mSAC1 intron 1, the pGT1dTM
splice-trap insertion site was first mapped to low resolution by Southern
blotting. By taking advantage of a unique SphI site in pGT1dTM, and of the
endogenous SphI and EcoNI sites in mSAC1 intron 1, we determined the
insertion lay within the proximal 2.9 kb of mSAC1 intron 1 (Figure 1B and
Supplemental Figure S2). The insertion site was mapped more precisely by
Figure 1. Genetic ablation of the mammalian
SAC1 gene. (A) SAC1 insertion mutation. ES
cells (NPX473) used to produce SAC1-deficient
mice carried a gene trap insertion of pGT1dTM
in the SAC1 locus. A 0.3-kb fragment upstream
of the vector SphI site, designated the Neo
probe, was used as a diagnostic probe in South-
ern blots. The insertion site within SAC1 intron
1 was determined by PCR. PCR primers: F1,
120bp@Intron1-F; F2, 310bp@Intron1-F; R1,
630bp@Intron1-R; R2,1730bp@pGTM-R; and R3,
1kb@pGTM-R (see Supplemental Table S1). Re-
striction sites: S, SphI; E, EcoNI. SA, splice ac-
ceptor. (B) Identification of gene-trap insertion
by Southern blot. Genomic DNA from SAC1/
and SAC1/0 ES cells was digested with SphI or
EcoNI or both, transferred to nitrocellulose, and
hybridized with radiolabeled Neo probe. Ar-
rows at right indicate the fragment released
from the double digestion was 0.5 kb smaller
than that released by SphI digestion.
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polymerase chain reaction (PCR) by using forward primers to walk down
mSAC1 intron 1 sequences. In those assays, a common reverse primer that
hybridizes uniquely to pGT1dTM was used (Figure 1A). A 1.1-kb product was
amplified using forward primer F1: 120bp@Intron1-F, which anneals 120 bp
downstream of the 5 end of the intron 1, and reverse primer R2:
1730bp@pGTM-R (Supplemental Table S1). This result was corroborated us-
ing forward primer F2: 310bp@Intron1-F (anneals 310 base pairs downstream
of the 5 end of intron 1) in combination with reverse primer R3:
1kb@pGTM-R (anneals 1 kb downstream of the 5 end of vector; Supplemen-
tal Table S1). Nucleotide sequences of these PCR products mapped the
pGT1dTM insertion site 400 bp downstream of the 3 end of mSAC1 exon 1.
Although we found rearrangements at both 5 and 3 ends of inserted vector
sequence, reverse transcriptase (RT)-PCR confirmed the msac1::-GEO inser-
tion generates an mRNA where mSac1 exon 1 is spliced to vector sequence
(data not shown).
Creation and Genotyping of SAC1 Mice
Bay Genomics line NPX473 ES cells are annotated to have a pGT1dTM
splice-trap insertion in intron 1 of the SAC1 gene, which presents a splice-
acceptor sequence upstream of a reporter gene -GEO. The precise pGT1dTM
insertion site was mapped by PCR and confirmed to reside in SAC1 intron 1.
SAC1/0 ES cells were injected into C57BL/6 blastocysts, and then they were
implanted into pseudopregnant foster mothers. Male chimeric mice compe-
tent for germ line transmission of the sac1::-GEO null allele were isolated and
mated with wild-type C57BL/6 females to generate SAC1/0 mice. Genotypes
of offspring derived from SAC1/0 mouse intercrosses were identified by a
three primer PCR assay by using a shared forward primer (120bp@Intron1-F),
a genomic reverse primer (630bp@Intron1-R), and an insertion-specific re-
verse primer (1kb@pGTM-R) to amplify wild-type SAC1 and mutant sac1
alleles (56°C annealing temperature; primer sequences Supplemental Table
S1). When necessary, two amplification cycles were performed in nested PCR
assays with the first cycle by using primers as described above. In the second
cycle, primers 310bp@Intron1-F and 1kb@pGTM-R were used to amplify the
mutant allele and primers 310bp@Intron1-F and 630bp@Intron1-R were used
to amplify the wild-type allele. The PCR products are 330 and 240 bp for
wild-type and mutant alleles, respectively. Staged embryos, blastocysts, and
postimplantation embryos were collected according to published protocols
(Nagy et al., 2003).
Cell Culture and Transfections
HeLa cells were cultured in DMEM supplemented with 10% fetal bovine
serum, 100 g/ml penicillin, and 100 g/ml streptomycin. Transfections used
Lipofectamine reagent (Invitrogen, Carlsbad, CA) according to manufactur-
er’s instructions.
siRNA-mediated Gene Silencing
hSAC1 siRNA duplexes were from Dharmacon RNA Technologies (Lafayette,
CO). HeLa cells were transfected with hSAC1 siRNA, or control siRNA, with
Lipofectamine reagent as described above. Total RNA was recovered from
SAC1 siRNA-treated and control cells 48 h after transfection and efficiency of
silencing was monitored by reverse transcription (RT)-PCR. PCR primers
were as follows: forward, 5-ATGTTCCTCCTTCAGCTGTC-3 and reverse,
5-TCAGGACTAGTGTT GGATAGC-3. Individual and combinatorial knock-
down of ADP-ribosylation factor (ARF)1 and ARF4 expression was accom-
plished as described previously (Volpicelli-Daley et al., 2005).
Fluorescence Microscopy and Video Processing
Cells were plated onto coverslips and treated with SAC1 siRNA oligonucle-
otides (oligos). Forty-eight to 72 h after siRNA treatment, control siRNA and
SAC1 siRNA-treated cells were fixed with 3.7% paraformaldehyde in phos-
phate-buffered saline (PBS) for 15 min, permeabilized with 0.2% Triton X-100
in PBS for 4 min, and washed with PBS. Permeabilized cells were blocked
with 2% bovine serum albumin (BSA) in PBS for 1 h, and then they were
incubated with respective antibodies in 2% BSA/PBS for 1 h. Cells were
incubated with primary antibodies for 1 h, washed four times (5 min each
wash) with PBS, and then incubated with fluorochrome-conjugated second-
ary antibodies for 1 h. Finally, cells were washed four times (5 min each wash)
with PBS, and coverslips were mounted in Fluosave (Calbiochem, San Diego,
CA). Cells were visualized by confocal microscopy (Leica SP2 aobs confocal
[Wetzlar, Germany] or Zeiss 510 laser scanning confocal [Carl Zeiss, Jena,
Germany]). All images were processed using Adobe Photoshop 6 (Adobe
Systems, Mountain View, CA). Z-stack images of single cells were obtained
(step size was 0.2–0.3 m), and they were projected into videos by using LSM
image browser software (Carl Zeiss).
Vesicular Stomatitis Virus Glycoprotein (VSV-G)
Transport Assays
HeLa cells treated with control or SAC1 siRNA were seeded onto coverslips
and 24 h after transfection, cells were transfected in a second round with
pEVFP-N1-VSV-G tsO45 (FuGENE transfection; Roche Diagnostics, Mann-
heim, Germany). Four hours after transfection, cells were shifted to 40°C and
incubated overnight at that temperature in growth medium. To study the
ER–Golgi–plasma membrane transport, cells were shifted to 32°C for various
times, fixed with 3.7% paraformaldehyde in PBS, and stained with anti-
GM130 antibody. To block VSV-G export from the trans-Golgi network
(TGN), cells were shifted from 40 to 32°C for 15 min, and then they were
incubated at 20°C for 2 h. The TGN block was released by shift to 32°C for the
indicated times, and cells were processed for immunofluorescence micros-
copy. The ratio of TGN VSV-G and total VSV-G fluorescence was then
calculated. In all cases, 100 g/ml cycloheximide was added 30 min before
the temperature downshift.
Silence-Rescue System
A rescue sequence was generated though cloning the wild-type or mutant
cDNA of mSAC1 into the pLentiLox 4.0 pLL4.0 vector. Rescue sequence
expression is under the control of the moderate UbC promoter, and the rescue
open reading frame is fused to a C-terminal green fluorescent protein (GFP)
tag to facilitate analysis. The wild-type mSAC1 was amplified from mouse
brain mRNA by reverse transcriptase-PCR by using primers MfeI site flanked
forward primer, 5-GGGCAATTGGCCACCATGGCGGCCGCAGCCT AC-
GAGCATC-3; and BamHI site flanked reverse primer, 5-CGGGATCCTCT-
CAGTCTATCTTTTCTTT CTGGAC-3. The PCR products were digested by
MfeI and BamHI and subcloned into the pLL4.0 vector though EcoRI and
BamHI sites. The msac1D391N and msac1R480H mutants were generated by
mutagenic primers as described above. The msac1AEAID mutant was generated
by PCR by using the following mutagenic primers: 5-CCCAGACTGGTC-
CAGGCAGAAGCGATAGACGGCGGAGGC-3 and 5-GC CTCCGCCGTC-
TATCGCTTCTGCCTGGACCAGTCTGGG-3. Correct clones were isolated
and virus was produced by transfecting human embryonic kidney (HEK)293
cells and collecting supernatant (Rubinson et al., 2003). Supernatant was then
used to infect HeLa cells to generate stably transfected HeLa cell lines. The
stable cell lines were selected by fluorescence-activated cell sorting (FACS)
using GFP luminescence as positive signal.
FACS Analysis
Cells were trypsinized and then dispersed in PBS supplemented with 5% fetal
bovine serum to obtain a single cell suspension. FACS was performed at the
University of North Carolina-Chapel Hill School of Medicine FACS facility.
Glycosaminoglycan (GAG) Release Assays
GAG assays were performed on control- or hSAC1 siRNA-challenged HeLa
cells, as described previously (Litvak et al., 2005).
Cell Synchronization via Thymidine Block
Cell cultures were first incubated in medium containing 2 mM thymidine
for 19 h. Cells were subsequently washed two times with PBS and fed with
fresh media lacking thymidine. After a 9-h incubation, the medium was
exchanged for fresh medium supplemented with 2 mM thymidine, and the
cultures were incubated for an additional 16 h. Alternatively, to arrest cells
in mitosis, cultures were incubated in medium containing 100 nM nocoda-
zole for 12–14 h.
5-Bromo-2-deoxyuridine (BrdU) Incorporation Assays
Cells grown on coverslips were labeled with 10 M BrdU (Sigma-Aldrich, St.
Louis, MO) for 2 h, and then they were fixed with 100% methanol for 10 min
at 20°C. The slides were subsequently incubated in 2 N HCl for 1 h at 37°C
to denature DNA, and washed twice for 10 min in 0.1 M borate buffer, pH 8.5,
to neutralize the acid. After three washes with PBS, slides were incubated
with Alexa Fluor 488-conjugated anti-BrdU antibodies (Invitrogen) diluted in
PBS containing 0.1% BSA for 1 h, washed three times for 10 min each,
mounted, and visualized by confocal microscopy. For FACS analysis, cells
grown to 90% confluence in 60-mm dishes were incubated with 10 M BrdU
containing media for 2 h. Labeled cells were trypsinized, harvested by cen-
trifugation, suspended in 0.5 ml of PBS, and fixed in 4.5 ml of 100% ethanol
overnight at 20°C. Fixed cells were centrifuged at 1000 rpm for 5 min and
then digested with 3 ml of 0.08% pepsin in 0.1 N HCl at 37°C for 20 min.
Nuclei were pelleted, denatured with 1.5 ml of 2 N HCl at 37°C for 20 min,
and neutralized with 3 ml of 0.1 M sodium borate. Nuclear pellets were
washed with IFA buffer (10 mM HEPES, pH 7.4, 150 mM NaCl, 4% fetal
bovine serum, 0.5% Tween 20, and 0.1% NaN3) and incubated with 100 l of
Alexa Fluor 488-conjugated anti-BrdU antibodies diluted 1:5 in 0.5% IFA
buffer at room temperature for 2 h. Nuclei were pelleted, washed with IFA
buffer, resuspended in 500 l of running buffer (0.5% IFA buffer, 200 g/ml
RNase A, and 1 g/ml propidium iodide), and processed for FACS.
Online Supplemental Material
Supplemental Figure S1 shows the domain organization of Sac1 phospha-
tases. Supplemental Figure S2 describes inactivation of the murine SAC1 gene
by gene trap. Supplemental Figure S3 describes the morbidity associated with
Sac1 depletion. Supplemental Figure S4 shows hSac1 depletion specifically
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affects disorganization of Golgi membranes. Supplemental Figure S5 docu-
ments increased cell and nuclear area in hSac1-depleted cells. Supplemental
Figure S6 shows hARF depletion results in disorganization of Golgi mem-
branes without affecting mitotic spindle organization. Supplemental Movies
S1 and S2 depict Z-stack projections of cis- and trans-Golgi membranes in a
representative wild-type cell from the perspective of the x-axis and z-axis,
respectively. Supplemental Movies S3 and S4 depict Z-stack projections of cis-
and trans-Golgi membranes in a representative hSac1-depleted cell with mod-
erately dispersed Golgi from the perspective of the x-axis and z-axis, respec-
tively. Supplemental Movies S5 and S6 depict Z-stack projections of cis- and
trans-Golgi membranes in a representative hSac1-depleted cell with severely
dispersed Golgi from the perspective of the x-axis and z-axis, respectively.
Supplemental Movie S7 shows the process of Golgi dispersal upon hSac1
depletion in living cells. Supplemental Movie S8 demonstrates hSac1-de-
pleted cells with multipolar spindles present only two centrosomes.
RESULTS
Murine Sac1 Is a PIP Phosphatase
Ablation of ySac1 PIP phosphatase function evokes pleiotro-
pic phenotypes that include a cold sensitivity for growth, Ins
auxotrophy, allele-specific genetic interactions with muta-
tions in the single yeast actin structural gene, and bypass for
the normally essential cellular requirement for Sec14, the
major yeast PtdIns/phosphatidylcholine transfer protein
(Cleves et al., 1989; Novick et al., 1989; Whitters et al., 1993).
Mutations that compromise ySac1 enzymatic activity phe-
nocopy sac1 null mutations, whereas substitutions outside
the ySac1 catalytic motif evoke defects that are likely regu-
latory in nature (Nemoto et al., 2000; Li et al., 2002). Several
lines of evidence demonstrate mSac1 shares a functional
relationship to ySac1. mSac1 expression in sac1 yeast res-
cued the Ins auxotrophy of these strains (Figure 2A). Phe-
notypic rescue requires lipid phosphatase activity as evi-
denced by the inability of “catalytic-dead” mSac1D391N
missense mutant expression to restore growth to sac1 yeast
under inositol-limiting conditions (Figure 2A). By contrast,
other missense substitutions that correspond to ySac1 LOF
mutations do not strongly compromise mSac1 activity.
mSac1A442V or mSac1R480H (i.e., analogues of the yeast
sac1-10 and sac1-22 gene products, respectively; Nemoto et
al., 2000) expression rescued Ins-auxotrophy in the sac1
mutant (Figure 2A). These results were recapitulated for
other sac1-associated phenotypes, e.g., cold sensitivity for
growth and “bypass Sec14” (data not shown).
PIP analyses from yeast radiolabeled with [3H]Ins were
consistent with the phenotypic rescue data. As demon-
strated previously (Guo et al., 1999; Rivas et al., 1999; Hughes
et al., 2000), ySac1 insufficiencies lead most strikingly to an
increase in PtdIns-4-P mass with modest elevation in PtdIns-
3-P. Whereas PtdIns-4-P and PtdIns-3-P constituted 0.8  0.1
and 1.1  0.1% of total Ins glycerophospholipid in wild-type
yeast, these values rose to 10.4  1.7 and 1.6  0.3% in the
sac1 mutant (Figure 2B). PtdIns-4,5-P2 and PtdIns-3,5-P2
species exhibited only subtle changes upon ySac1 LOF (data
not shown). mSac1 expression in sac1 yeast restored Pt-
dIns-4-P and PtdIns-3-P to wild-type levels (1.6  0.3 and
0.9  0.2%), whereas mSac1D391N expression was ineffective
(PtdIns-4-P and PtdIns-3-P values of 8.4  0.4 and 1.7 
0.4% in the sac1 mutant, respectively; Figure 2B).
mSac1A442V or mSac1R480H expression also corrected sac1-
associated derangements in PIP homeostasis. The
mSac1A442V-expressing sac1 yeast strain exhibited frac-
tional values for PtdIns-4-P and PtdIns-3-P of 3.1  0.8 and
1.3  0.2%, respectively, whereas those values for the
mSac1R480H-expressing sac1 mutant were 2.8  0.8 and
1.5  0.1% (Figure 2B).
Sac1 and Cargo
A stable HeLa cell line was generated that expresses a func-
tional mSac1-GFP chimera. The expression level for the ec-
topically expressed mSac1-GFP was approximately three-
fold greater than that of endogenous hSac1 (see below).
Under those conditions, mSac1-GFP colocalized with an ER
marker (calnexin), a cis-Golgi marker (GM130), and a TGN
marker (TGN46; Figure 3A). This pattern is in agreement
with the distribution of endogenous Sac1 in mammalian
cells (Nemoto et al., 2000; Rohde et al., 2003). mSac1-GFP
showed a higher degree of colocalization with the cis-Golgi
marker GM130 than with the TGN marker TGN46 (Figure
3A). The presence of mSac1 in Golgi cisternae (particularly
TGN) is paradoxical given PtdIns-4-P is important for an-
terograde trafficking from the TGN (Hama et al., 1999;
Walch-Solimena and Novick, 1999; Godi et al., 2004). One
possibility is mSac1 is disqualified from efficient entry into
Golgi subregions from which anterograde vesicles bud.
To investigate whether mSac1 is indeed excluded from
such subregions of mammalian Golgi membranes, the colo-
calization of mSac1-GFP with an anterograde cargo mole-
cule was monitored. The cargo marker was represented by a
red fluorescent protein (RFP)-tagged version of the tsO45
mutant version of VSV-G protein (RFP-tsO45-VSV-G). The
mSac1-GFP–expressing HeLa cell line was transfected with
Figure 2. mSac1 is a PIP phosphatase. (A) mSac1 complements
ySac1 defects. Strain CTY244 (sac1) was transformed with yeast
episomal plasmids that drive expression of mSAC1, mutant msac1
alleles encoding mSac1D391N, mSac1A442V, and mSac1R480H, respec-
tively, as well as a URA3 control. Strains were spotted in 10-fold
dilution series onto Ins-replete and Ins-depleted media and incu-
bated at 26°C for 4 d. (B) PIPs in sac1 strains. SAC1 yeast, and
isogenic sac1 mutants carrying YEp(URA3), YEp(mSAC1),
YEp(msac1D391N), YEp(msac1A442V), or YEp(msac1R480H) were labeled
with [3H]Ins for at least 18 h, PLs were extracted and deacylated in
the presence of methylamine, and the glycerol-phosphoinositol spe-
cies were resolved by anion exchange chromatography and quan-
tified. PtdsIns-3-P and PtdIns-4-P are represented as percentages of
total deacylatable Ins-phospholipid (PL). Data are expressed as
mean values calculated from at least three independent experi-
ments. Standard deviations are given (*p  0.01 and **p  0.001).
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constructs driving RFP-tsO45-VSV-G expression. Trans-
fected cells were incubated at 40°C to accumulate biosyn-
thetic RFP-tsO45-VSV-G in the ER (Presley et al., 1997; Scales
et al., 1997). A wave of RFP-tsO45-VSV-G was then released
from the ER into the secretory pathway by downshift of cells
to 32°C. Partial colocalization of mSac1-GFP with RFP-
tsO45-VSV-G was recorded when this cargo was transported
from ER to the Golgi (Figure 3B). However, mSac1-GFP did
not follow the RFP-tsO45-VSV-G cargo wave from Golgi to
the plasma membrane (Figure 3C). The data indicate mSac1
partially incorporates into cargo-containing subregions of
Golgi membranes. This incorporation is most pronounced in
cis-Golgi compartments, but it is not obvious in late Golgi
compartments.
Murine Sac1 Nullizygosity Results in Early Embryonic
Lethality
Reproductive activity of msac10 sperm and eggs is not af-
fected. Cross of mSAC1/0 males to mSAC1/ females, and,
reciprocally, mSAC1/0 females to mSAC1/ males yielded
heterozygous progeny at frequencies approximating the ex-
pected 50% value (52 mSAC1/: 61 mSAC1/0 and 24
mSAC1/: 31 mSAC1/0, respectively). However, geno-
typic analysis of live progeny derived from intercross of
Figure 3. Localization of ectopically ex-
pressed mSac1 in HeLa cells. (A) A stable cell
line expressing mSac1-GFP was stained with
antibodies directed against GM130, TGN46, or
-calnexin. Bars, 10 m. (B) HeLa cells stably
expressing mSac1-GFP were transiently trans-
fected with plasmids that drive expression of
RFP-tsO45-VSV-G. cis-Golgi membranes were
marked by GM130. Merged images highlight
colocalization of mSac1-GFP with RFP-tsO45-
VSV-G cargo. Bars, 10 m. (C) mSac1-GFP
HeLa cells were transfected with the plasmid
expressing RFP-tsO45-VSV-G. Four hours af-
ter transfection, cells were shifted to 40°C and
incubated overnight to trap the newly synthe-
sized RFP-tsO45-VSV-G in the ER. The re-
tained ER pool was released into the secretory
pathway by downshift to 32°C for the indi-
cated time periods. Cells were fixed, immuno-
stained for Golgin-97, and processed for im-
munofluorescence microscopy. Bars, 20 m.
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SAC1/0 animals indicate msac1::-GEO is a lethal and fully
penetrant autosomal recessive mutation (Figure 4A). Further
analyses revealed early developmental failure for mSac1-
deficient animals. Of the 178 embryos harvested in the de-
velopmental window ranging from E3.5 to E12.5 (96 of
which were collected at E3.5), a genotypic distribution of 51
mSAC1/; 107 mSAC1/0; 7 msac10/0 was recorded (Figure
4B). Of the seven msac10/0 progeny recovered, a single
grossly malformed embryo was recovered at embryonic day
(E)7.5. The remaining embryos were recovered at the E3.5
blastocyst stage with no obvious structural abnormalities. In
sum, we recovered a genotypic distribution of 157
mSAC1/; 290 mSAC1/0; 7 msac10/0. In total, 13 resorp-
tions occurred during the E7.5–E11.5 developmental win-
dow. The preimplantation lethality suggests mSac1 executes
an essential housekeeping function. In support of this con-
clusion, challenge of HeLa cells with siRNA directed against
human SAC1 (hSAC1) mRNA results in clear and specific
compromise of cell viability (Supplemental Figure S3A).
Flow cytometry analyses recorded significant elevations in
the sub-G1 (morbid or dead cell) load in hSac1-depleted cell
populations (Supplemental Figure S3B). Consistent with a
nonapoptotic pathway for cell death, morbidity of hSac1-
deficient cells was not rescued by pharmacological challenge
with the pan-caspase inhibitor Z-VAD-fmk (data not shown).
hSac1 Deficiencies Evoke Structural Derangements of the
Golgi System
The morbidity of Sac1-deficient mammalian cells, when cou-
pled with the ER/Golgi localization of this PIP phosphatase,
implicated ER and/or Golgi membranes as likely casualties
of Sac1 dysfunction. To assess the functional competence of
the ER and Golgi systems under conditions of Sac1 insuffi-
ciency mammalian cells, the siRNA approach was again
used with HeLa cells as primary experimental model. Given
mSAC1/0 mice exhibit no overt phenotype, and given that
embryonic fibroblasts derived from mSAC1/0 mice are ro-
bust, the cellular Sac1 threshold for functional sufficiency is
necessary below 50% of wild-type expression levels. In that
regard, the siRNA strategies used achieved bulk knockdown
efficiencies of 50–60% in HeLa cell populations as judged
by RT-PCR (Figure 5A). Immunoblotting experiments con-
firmed that bulk hSac1 levels were reduced in siRNA-treated
HeLa cell populations (Figure 5B). Because these data rep-
resent averaging estimates, we think it most likely silencing
efficiency reflects a condition where a fraction of cells is
effectively silenced for hSAC1 expression, rather than a sit-
uation where all cells exhibit uniform reductions in hSAC1
expression.
A dramatic phenotype associated with hSac1 depletion is
disorganization of the Golgi system. Some 60% of HeLa cells
in the hSac1-depleted condition exhibited dispersal of cis-,
medial-, and trans-Golgi compartments to what we classify as
“moderately dispersed” and “severely dispersed” arrange-
ments. The moderately dispersed arrangement is defined by
relaxation of the compact Golgi structure into a reticular
arrangement, whereas the severely dispersed condition is
typified by extensive fragmentation of the Golgi system
(Figure 5C; see Supplemental Movies S1–S6). The Golgi
dispersal phenotype, regardless of severity, was consistent
throughout the stack, i.e., Golgi with severely dispersed
cis-Golgi compartments exhibited severely dispersed TGN,
whereas Golgi with moderately dispersed cis-Golgi pre-
sented moderate TGN dispersion. Incorporation of the pan-
caspase inhibitor Z-VAD-fmk during the silencing protocol
had no significant effect on the frequency of cells presenting
deranged Golgi morphology upon hSac1 depletion (data not
shown). These findings indicate onset of the Golgi morphol-
ogy phenotype is not a consequence of activating apoptotic
pathways. Time-lapse video microscopy of HeLa cells stably
coexpressing a -1,4-galactosyltransferase-GFP Golgi
marker, and an mCherry-histone H2B nuclear marker, were
challenged with hSAC1 siRNA and imaged at 30 h post-
siRNA treatment. Onset of Golgi disorganization is docu-
mented in Supplemental Movie S7. Of the 194 cells scored,
76% developed deranged Golgi organization—a frequency
in accord with experiments where fixed cells were imaged.
The effects on Golgi structure represented specific effects
of hSAC1 silencing based on several criteria. First, the hSAC1
siRNA-mediated Golgi dysmorphology was not limited to
HeLa cells. The effect was recapitulated in other human cell
lines such as HEK293 (Figure 5D). Moreover, neither the
striking disruption of Golgi architecture, nor the reduction
in Sac1 expression levels, was observed when nonhuman
cells (e.g., COS-7) were treated with hSAC1 siRNA oligonu-
cleotides, or when HeLa cells were challenged with irrele-
vant hPITP siRNA oligonucleotides (although hPITP ex-
pression was effectively silenced; data not shown).
Endomembrane specificity to the hSAC1 siRNA effect was
also observed. hSac1 depletion levied no obvious effects on
lysosomal, endosomal, mitochondrial, or ER architecture
(Supplemental Figure S4A). Finally, Golgi disorganization
was rescued by expression of a silencing-resistant mSac1-
GFP (see below).
Disorganized Golgi Retain Transport Competence
Three lines of evidence indicate structural compromise of
Golgi membranes upon hSac1 depletion does not levy
strong defects in anterograde membrane transport. First, the
transport efficiency was monitored for a synchronized wave
of tsO45-VSV-G trafficking from the ER to the Golgi system,
and from the Golgi to the plasma membrane. No significant
deviation was recorded between hSac1-depleted versus
wild-type control cells in either transport stage (Figure 6,
A–C). Second, [35S]sulfate pulse-chase experiments demon-
Figure 4. Preimplantation lethality of msac10/0 mice. (A and B)
Genotypic distributions. mSAC1 genotypes of the 289 live-born F1
progeny produced by intercrosses of SAC1/0 mice (A), as well as
the 165 F1 embryos harvested in an E3.5–E12.5 window from par-
allel heterozygote matings (B) are shown.
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Figure 5. hSAC1 silencing and Golgi morphology. (A) HeLa cells were challenged with hSAC1 or control siRNA oligonucleotides, and total
cell RNA was harvested after 24 h. The total RNA fraction was used to template cDNA synthesis by reverse transcription (RT), and the RT
products were used to template amplification of a 300-base pair fragment of hSAC1. Reactions were normalized by amplification of a 300-bp
product derived from laminin mRNA. (B) HeLa cells were treated with hSAC1 or control siRNA oligonucleotides. After 24 and 72 h, hSac1
levels were analyzed by immunoblot from lysates prepared from 104 cells. Actin was monitored as normalizing control. (C) Forty-eight hours
after SAC1 siRNA treatment, HeLa cells were fixed and imaged for GM130 and TGN46. Representative images of hSAC1 siRNA-treated, or
control siRNA cells are shown. Golgi morphology was defined as “compact” (C), moderately dispersed (MD) or severely dispersed (SD).
Distributions (expressed as percentages) of each category of Golgi membranes was compared for hSac1-depleted cells relative to controls
(right). These were calculated as mean values (with standard deviations) from three independent experiments with 100 cells scored per
experiment. Bar, 20 m. (D) Golgi morphology in hSac1-depleted HEK293 cells. Over 60% of hSAC1 siRNA cells exhibited dispersed Golgi
membranes. Data were obtained from two independent experiments with 100 cells scored per experiment. Bar, 20 m.
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Figure 6. Sac1 depletion does not compromise membrane trafficking. (A and B) hSac1 depletion does not affect protein transport from the
ER to the Golgi or from the Golgi to the plasma membrane. HeLa cells challenged with control and hSAC1 siRNAs were transfected with a
construct that expresses the temperature-sensitive mutant ts045-VSV-G-yellow fluorescent protein (YFP), incubated at 37°C for 4 h, and then
at 40°C overnight to accumulate VSV-G in the ER. Cyclohexamide (100 g/ml) was added to cells, and 30 min later cells were shifted to 32°C
to release the VSV-G transport along the secretory pathway. Cells were fixed and imaged at different time points as indicated. The Golgi is
visualized by staining with the GM130 antibody (red), and VSV-G-YFP is shown as green in the figure. The rate of VSV-G export from the
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strated both rate and efficiency of transport of newly syn-
thesized GAGs from the TGN to the plasma membrane were
uncompromised in hSac1-depleted cells (Figure 6D). Third,
[35S]methionine pulse-chase analyses in hSac1-depleted cell
cultures, reported normal biosynthetic transport of trans-
ferrin receptor from ER to Golgi, as assayed by conversion of
core-glycosylated transferrin receptor to an endoglycosidase
H-resistant state (data not shown).
The possibility that hSac1 deficiency evokes mislocaliza-
tion of PtdIns-4-P-binding proteins from the Golgi complex
was considered. Such an effect could arrive as a consequence
of PtdIns-4-P accumulating to high levels on inappropriate
membrane surfaces, e.g., ER (Li et al., 2002). [3H]Inositol
radiolabeling experiments, coupled with analyses of PIP
species, reports a modest but reproducible (30%) increase
in PtdIns-4-P in hSac1-deficient cell populations relative to
controls (Supplemental Figure S4B). Given the silencing ef-
ficiency, this translates to an 50–60% increase in cellular
PtdIns-4-P in depleted cells. To determine whether such
increase is of sufficient magnitude to redistribute PIP bind-
ing proteins, we followed the localization of endogenous
TGN-associated PIP-binding proteins under conditions of
Sac1 depletion. These include the two FAPP proteins
(FAPP1 and FAPP2) whose localization to TGN membranes
is controlled by a pleckstrin homology (PH)-domain that
binds PtdIns-4-P (Godi et al., 2004). The targeting fidelity of
an FAPP1 PH-domain-mCherry reporter was maintained in
hSac1-depleted HeLa cells with dispersed Golgi membranes
(Figure 7A). Association of endogenous FAPP1 and FAPP2
with HeLa TGN was similarly undisturbed (data not
shown). Localization of Orp9, a Golgi-targeted member of
the oxysterol binding protein family (Lessmann et al., 2007;
Wyles and Ridgway, 2004), was also unimpressed by hSac1
depletion (Figure 7B). The structurally deranged Golgi sys-
tem in hSac1-depleted cells retained its cohort of other pe-
ripheral Golgi proteins as well, including -COP (Chen et al.,
2005; Duden et al., 1991; Oprins et al., 1993) (Figure 7C) and
the TGN-associated phosphatidylinositol transfer protein
(PITP) (Phillips et al., 2006) (Supplemental Figure S4C).
Finally, as the severely dispersed Golgi phenotype of hSac1-
depleted cells is similar to the effects imposed by nocodazole
challenge, we also monitored status of microtubules (MTs)
in such cells. The MT cytoskeleton was superficially normal
in hSac1-deficient cells, even in those with highly frag-
mented Golgi membranes (Figure 7D).
hSac1 Depletion and Cell Spreading
Another prominent morphological feature of cells treated
with hSAC1 siRNAs is an approximately 2.3-fold increase in
cell spreading area (2325  791 m2) relative to controls
(995  228 m2; Supplemental Figure S5A). Increased cell
spreading correlated with magnitude of Golgi structural
derangement. That is, HeLa cells with severely dispersed
Golgi membranes exhibited pronounced increases in cell
spreading area (2958  1246 m2; 2.9-fold increase relative
to mock control cells), and those with moderately dispersed
Golgi showed moderate increases in cell spreading area
(1754  530 m2; approximately an average 1.8-fold increase
relative to mock control cells). hSac1-depleted HeLa cells
also exhibited larger nuclei compared with controls, and the
magnitude of nuclear enlargement was directly proportional
to cell spreading area and severity of the Golgi architectural
derangement. Those cells with moderately and severely dis-
persed Golgi membranes exhibited 1.3- and 2.0-fold en-
largements in nuclear area compared with controls, respec-
tively (Supplemental Figure S5B).
The large increases in cell spreading area suggested cy-
toskeletal alterations in hSac1-depleted cells. One mecha-
nism for inducing such increases in cell surface area is
diminished formation of dorsal filopodia (Bohil et al., 2006).
However, scanning electron microscopy revealed no signif-
icant reductions in dorsal surface filopodial density in
hSac1-insufficient cells (0.34  0.14 filopodia/m2) com-
pared with controls (0.46  0.09 filopodia/m2). Functional
ablation of ySac1 alters yeast actin organization (Novick et
al., 1989), an effect interpreted as an indirect consequence
derived from deregulated interactions between actin bind-
ing proteins and PIPs (Cleves et al., 1991; Whitters et al.,
1993). Visualization of F-actin by phalloidin staining showed
no dramatic disorganization of actin stress fibers in hSac1-
depleted cells, although stress fibers seemed more pro-
nounced relative to those in controls (Supplemental Figure
S5C).
hSac1 and Organization of the Mitotic Spindle
To investigate cell cycle progression in hSac1-depleted cells
more directly, an asynchronous HeLa cell population was
challenged either with control or SAC1 siRNAs, and BrdU
incorporation and propidium iodide staining were both
monitored as readouts for DNA content. Relative to con-
trols, hSac1-depleted populations exhibited fewer cells in S
phase 48 h after siRNA challenge (26 vs. 14%, respectively).
This decrease was accompanied by a compensating increase
in the G2/M population (4 vs. 15% of total cells, respec-
tively; Figure 8A). Experiments where cells were synchro-
nized at the G1/S boundary by a double-thymidine block
strategy (see Materials and Methods) further buttressed these
findings. At 12 h after release from G1/S arrest, cells with
severely or moderately dispersed Golgi membranes were
underepresented in the S phase cell population relative to
controls (32 vs. 46 vs. 74%, respectively; Figure 8B), suggest-
ing that cells with disorganized Golgi membranes do not
progress efficiently though G2/M. To assess the effects of
hSac1 depletion on cell cycle progression though G2/M
phase, hSAC1 siRNA treated and control cells were arrested
in mitosis by nocodazole treatment (100 nM) for 12–14 h.
Arrested cells were fixed, permeablized, and double-labeled
for -tubulin and DNA. Consistent with a difficulty for
hSac1-depleted cells to traverse G2/M, only ca. 1% of the
cells in hSac1-depleted populations escaped from the no-
codazole-induced prometaphase block and progressed to
anaphase or telophase. This frequency is reduced relative to
Figure 6 (cont). ER to the Golgi, and from the Golgi to the plasma
membrane was measured by comparing the ratio of ER-associated,
Golgi-associated VSV-G, and plasma membrane-associated VSV-G
to total VSV-G fluorescence for each time point. Data are from three
independent experiments, with 100 cells imaged per time point
per experiment. Bar, 20 m. (C) hSAC1 silencing does not affect
protein transport from the Golgi to the plasma membrane. The
Golgi is visualized by a TGN marker, TGN46 antibody (red), and
VSV-G-YFP is rendered green in the figure. Rate of VSV-G export
from the Golgi to the plasma membrane was estimated by compar-
ing the ratio of Golgi-associated VSV-G, and plasma membrane-
associated VSV-G to the total VSV-G fluorescence for each time
point. The data are from three independent experiments, with 100
cells per time point per experiment. Bar, 20 m. (D) hSac1 depletion
does not inhibit release of [35S]GAGs from HeLa cells. Control and
hSAC1-depleted HeLa cells were incubated with xyloside (15 min),
pulse-labeled with [35S]sulfate (5 min), and then chased for the
indicated times. [35S]GAGs were precipitated from supernatant and
cell pellet fractions with cetylpyridinium chloride, and quantified.
The radioactivity of [35S]GAGs in the supernatant was compared
with total radioactivity, presented as a percentage, and plotted
against time. Data are from three independent experiments.
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the 12% of control cells that escaped the G2/M arrest
(Figure 8C).
In addition to the reduced frequency of hSac1-deficient
escapers from the G2/M-arrested cell population, we ob-
served an 10-fold elevation in the frequency of mitotic
hSac1-depleted cells with abnormal multipolar spindles
(Figure 8C). These ectopic spindles were mechanically com-
petent, because 4,6-diamidino-2-phenylindole (DAPI) stain-
ing indicated these spindles powered aberrant segregation
of chromosomal material. Again, the increased incidence of
cells with multipolar spindles in hSac1-depleted cell popu-
lations was not affected by treatment with the caspase in-
hibitor Z-VAD-fmk (data not shown). Multipolar spindles
can result from deregulated centrosome duplication fol-
lowed by MT nucleation at ectopic centrosomes (Hinchcliffe
and Sluder, 2001; Khodjakov and Rieder, 1999). Thus, we
surveyed the status of -tubulin (marks the ring structure
that nucleates spindle MT assembly; Moudjou et al., 1996)
and centrin-2 (a component of the centriole that regulates
centriolar duplication; Salisbury et al., 2002). The data con-
sistently reported multiple -tubulin foci in cells with mul-
tipolar spindles. Of the cells with multiple spindle asters;
however, 95% presented only two centrin-2 foci. These
data indicate centrosome duplication occurred normally in
hSac1-deficient cells (Figure 9, A and B and Supplemental
Movie S8).
Functional Properties of Mammalian Sac1
The Golgi morphological derangements and spindle disor-
ganization associated with hSac1 depletion presented facile
readouts for dissecting functional properties of mammalian
Sac1. To that end, and to confirm that the Golgi and spindle
structural defects reported a specific effect of reduced hSac1
function, wild type and mutant variants of a silencing-resis-
tant mSAC1-GFP gene fusion were individually expressed in
HeLa cells from a lentiviral expression vector. mSAC1-GFP–
expressing cells were challenged with hSAC1 siRNA oligo-
nucleotides. Morphological status of the Golgi was assessed
by monitoring distribution of the trans-Golgi marker
TGN46, whereas spindle organization was monitored by
visualization of -tubulin. These parameters were followed
in hSac1-depleted cells individually expressing 1) the
mSac1-GFP chimera, 2) mSac1-GFP variants with graded
compromise of Sac1 PIP phosphatase activity, or 3) mSac1-
GFP derivatives incompetent for binding to the COP1
coatomer that regulates trafficking of this enzyme.
mSac1-GFP expression efficiently rescued the Golgi and
spindle disorganization evoked by hSAC1 siRNA challenge
(Figure 10, A, B, and D). Similarly, expression of the substan-
tially functional mSac1R480H-GFP levied a partial, but signifi-
cant, rescue of the same. mSac1-GFP expression also corrected
the enhanced cell spreading of hSac1-depleted cells (data not
shown). By contrast, expression of the catalytically inactive
Figure 7. hSac1-deficiency and PIP-binding proteins. (A) Twenty-
four hours post-siRNA treatment, control and hSAC1 siRNA-chal-
lenged cells were transfected with a construct that expresses a
FAPP1 PH-domain-cherry sensor for PtdIns-4-P. Twenty-four hours
after transfection, cells were processed for immunofluorescence mi-
croscopy. Golgi membranes were visualized with GM130. Images
are representative of those obtained in two independent experi-
ments where 100 cells were scored per experiment. Bar, 10 m. (B)
hSac1-depleted HeLa cells were fixed, permeabilized, and codeco-
rated with primary antibodies directed against endogenous Orp9
and GM130. Bar, 20 m. (C and D) hSac1-depleted HeLa cells were
fixed and decorated with antibodies directed against -COP or
-tubulin. -COP-stained cells were triple-stained with antibodies
directed against the cis-Golgi marker GM130, and the trans-Golgi
marker TGN46. Images shown are representative of 100 cells
scored. Bar, 20 m.
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Figure 8. hSac1-depletion evokes mitotic defects. (A) At various times after transfection, hSAC1- or control siRNA-treated HeLa cells were incubated
with BrdU-supplemented growth media for 3 h, trypsinized, fixed, stained with propidium iodide, and processed for FACS analysis. Some 104 cells were
analyzed in each FACS experiment. Distribution of cells at different stages of the cell cycle (G1, S, G2/M, and replication stress) is shown as percentages
of total cell number. The data either represent mean values from two independent experiments, or mean values with standard deviations from three
independent experiments (*p  0.05 and **p  0.001). (B) SAC1 and control siRNA transfected cells were synchronized at G1/S by double thymidine block
and pulsed with BrdU for 2 h at 56 h after siRNA treatment. Cells were fixed and double stained with antibodies to BrdU (green) and the trans-Golgi
marker TGN46 (red). Data are from two independent experiments, and 400 cells were examined from three independent transfections per experiment
(**p  0.001). Bar, 20 m. (C) Thirty hours after siRNA challenge, hSAC1 and control siRNA-challenged cells were incubated with growth media
containing 100 nM nocodazole for 12–16 h to accumulate mitotic cells. Cells were fixed and stained for -tubulin (green) and DAPI. Representative images
of spindle and chromosome organization in control and Sac1 depletion conditions are shown. Data are from three independent experiments with three
independent transfections per experiment. In total, 400 cells were examined (*p  0.01 and **p  0.001). Bar, 10 m.
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mSac1D391N-GFP was ineffective in correcting the structural
derangements of either the HeLa Golgi system, or the spindle
apparatus, in cells challenged with hSAC1 siRNA oligonucle-
otides (Figure 10, A, B, and D). Mammalian Sac1 harbors a
C-terminal 583KEKID587 COP1-binding motif that promotes
retrograde trafficking of this enzyme from Golgi compartments
back to the ER. Inactivation of this motif by converting the K
residues to A results in Sac1 accumulation in the Golgi system
(Rohde et al., 2003). Expression of mSac1AEAID-GFP, a mutant
mSac1 for which the 583KEKID587 COP1-binding motif is com-
Figure 9. Centrosome duplication in hSac1-deficient cells. (A) Asynchronous cell populations challenged with hSAC1- or control siRNAs
were stained for -tubulin (green) and DAPI. Representative images of -tubulin foci (centrosomes) and DNA are shown. Data were derived
from three independent experiments, and 400 cells were examined from three independent transfections per experiment (**p  0.001). Bar,
10 m. (B) Experimental conditions were as described in A, except cells were stained for the centrosome marker centrin-2 (green), -tubulin
(red), and DAPI (blue). Representative images are shown. Only two centrin-2 foci are apparent in cells with multiple spindle asters. Bar, 10
m.
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promised, was ineffective in rescuing derangements in Golgi
or spindle organization inflicted by hSac1 depletion (Figure
10, C and D). Nonfunctionality of mSac1D391N-GFP and
mSac1AEAID-GFP in the complementation assay was not a triv-
ial result. The biologically inactive mSac1D391N-GFP and
mSac1AEAID-GFP, and the partially functional mSac1R480H-
GFP, all accumulated to steady-state levels similar to those
measured for mSac1-GFP (Figure 10E).
Figure 10. Functional properties of Sac1.
(A) HeLa cell lines that express wild type
mSac1-GFP, mSac1D391N-GFP, or
mSac1R480H-GFP from a stably integrated
lentiviral vector were challenged with con-
trol or hSAC1 siRNAs and processed for im-
munofluorescence microscopy. Golgi are
marked by GM130 (yellow), and mSac1-GFP
and mutant variants are shown as green.
Bar, 20 m. (B) Golgi membranes of cells
described in A were classified as compact
(C), moderately dispersed (MD), or severely
dispersed (SD). More than 300 cells were
examined for Golgi morphology. Data are
presented as mean values and standard de-
viations obtained from three independent
experiments with 100 cells examined per
experiment (*p  0.05 and **p  0.001). (C)
HeLa cells expressing mSac1AEAID–GFP
from an integrated lentiviral vector were
treated with control- or hSAC1-siRNAs and
processed for immunofluorescence. More
than 300 cells were examined for Golgi mor-
phology. Data are presented as mean values
and standard deviations obtained from three
independent experiments with 100 cells
examined per experiment (*p  0.01 and
**p  0.001). Bar, 20 m. (D) Sac1 phospha-
tase activity and coatomer binding and res-
cue of the spindle defects. siRNA experi-
ments were performed with wild-type
HeLa and lines expressing mSac1-GFP,
mSac1D391N-GFP, or mSac1AEAID-GFP. For-
ty-eight hours after siRNA challenge, cells
were fixed and spindle morphology was vi-
sualized by -tubulin staining. Data are
summed from three independent experi-
ments, and 400 cells were examined from
three independent transfections per experi-
ment (*p  0.05 and **p  0.001). (E) HeLa
cells expressing mSac1-GFP, mSac1D391N-
GFP, mSac1R480H-GFP or mSac1AEAID-GFP
from an integrated lentiviral vector were
processed for immunoblotting with anti-
hSac1, anti-GFP, and anti-actin antibodies.
HeLa cells with no GFP transgene served as
controls.
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Functional Distinction between Mammalian Sac1 and
ARF Depletion
The coatomer binding requirement for hSac1 function is
consistent with ER localization as an essential feature of
hSac1 biological activity. Alternatively, it could indicate a
role for hSac1 in biogenesis of COP1 vesicles. A COP1-
centric model implies a critical involvement for hSac1 in ER
retrieval pathways. Previous depletion studies with the Arf1
and Arf4 isoforms lend weight to this possibility (Volpicelli-
Daley et al., 2005). Codepletion of Arf1 and Arf4 evokes
Golgi dysmorphologies resembling the ones observed upon
hSac1 depletion. To distinguish between these possibilities,
two experiments were performed. First, we tested whether a
soluble resident of the ER lumen (BiP), a protein actively
retrieved from the Golgi by the KDEL receptor pathway
(Bole et al., 1986; Lewis and Pelham, 1992; Orci et al., 1997),
is inappropriately secreted in hSac1-depleted cell popula-
tions. This is expected if hSac1 is required for formation of
COP1 vesicles that help retrieve BiP. No significant increase
in extracellular BiP was detected in culture supernatants of
hSac1-depleted cells relative to controls (data not shown).
Second, we adopted the approach of Volpicelli-Daley et al.
(2005) and codepleted HeLa cells of both Arf1 and Arf4. As
described previously, such codepletion results in wholesale
release of the -COP subunit of the coatomer complex from
Golgi membranes and evokes dramatic dispersal and tubu-
lation of Golgi membranes (Supplemental Figure S6). Al-
though the Golgi dispersal phenotype is superficially similar
to the effects seen upon hSac1 depletion, we note Golgi
membranes retain coatomer under conditions of hSac1 in-
sufficiency (see above). Moreover, neither individual deple-
tion of Arf1 or Arf4 nor codepletion of both Arf1 and Arf4
had any effect on mitotic spindle organization in Arf-defi-
cient cell populations (Supplemental Figure S6). The collec-
tive data indicate hSac1 deficiency interfaces with Golgi
organization and mitotic spindle function in a manner that is
not tightly linked to activity of the Arf/coatomer system. We
conclude the functional requirement for the physical inter-
action between hSac1 and coatomer reflects the necessity of
hSac1 to reside in the ER, rather than an hSac1 requirement
for Arf/coatomer function.
DISCUSSION
Herein, we report a comprehensive analysis of mammalian
Sac1 PIP phosphatase function. We demonstrate loss of Sac1
activity leads to preimplantation lethality in the mouse.
Consistent with an essential housekeeping function for
mammalian Sac1, hSac1 depletion is deleterious to the cell
viability of immortalized human cell lines, and this morbid-
ity is associated with inefficient progression though the
G2/M phase of the cell cycle. From an intracellular perspec-
tive, Sac1 insufficiencies manifest themselves in specific de-
rangements of Golgi membrane architecture that are appar-
ent across all Golgi subcompartments, and in mitotic arrest.
The pronounced mitotic arrest associated with hSac1 deple-
tion is characterized by a highly elevated incidence of cells
with ectopic mechanically active spindles. Finally, rescue
studies establish that 1) the Golgi and mitotic spindle defects
result from hSac1 insufficiency and not depletion of some
other unintended target; 2) specific loss of Sac1 phosphatase
activity is sufficient to evoke the Golgi membrane and mi-
totic spindle disorganization; and 3) competence for COPI-
dependent recycling from the Golgi system back to the ER,
represents an essential property for mammalian Sac1 func-
tion in vivo.
Sac1 and Golgi Membrane Architecture
An attractive mechanism for Golgi disorganization under
conditions of hSac1 insufficiency is release of peripheral
membrane proteins that regulate the architecture of this
organelle. Given that catalytic activity of mammalian Sac1 is
required for rescue of the Golgi dysmorphology phenotype,
one attractive possibility is disorganization of the Golgi
system is evoked by mislocalization of specific PIP-binding
proteins. Such mislocalization could result from precocious
accumulation of PtdIns-4-P pools in inappropriate mem-
brane compartments (as demonstrated in sac1 yeast; Li et
al., 2002). Marker localization experiments, however, do not
report a significant redistribution of candidate PIP-binding
proteins. No obvious mislocalization of Golgi-associated Pt-
dIns-4-P-binding proteins was recorded in hSAC1-silenced
cells. Thus, derangement of cellular PtdIns-4-P is either lim-
ited to a quantitatively minor pool that does not lead to a
manifest redistribution of peripheral Golgi membrane pro-
teins that bind PtdIns-4-P, or excess PtdIns-4-P is effectively
sequestered by other high-affinity binding proteins. An al-
ternative possibility is activities of other proteins that control
Golgi structure and function (e.g., ARF) are compromised by
hSac1 deficiencies. We find no evidence to support this view
either. The lack of perturbation, by hSac1 insufficiency, of
PtdIns-4-P-binding protein distribution, ARF pathway func-
tion, or PITP association with Golgi membranes is congru-
ent with the transport competence of the disorganized Golgi
system. This conclusion holds the caveat that all measure-
ments of secretory pathway efficacy were conducted under
conditions of reduced hSac1 function. All hSac1-insuffi-
ciency phenotypes are expected to be more extreme under
conditions of Sac1 nullizygosity. It remains possible that a
defect is imposed on membrane trafficking through and
from the mammalian Golgi stack under authentic Sac1 null
conditions.
Sac1 and Progression through the Cell Cycle
Preservation of trafficking competence for the disorganized
Golgi membranes of hSac1-depleted cells suggests the mor-
phological defect reflects compromise of some other layer of
structural regulation for this organelle. In that regard, the
mammalian Golgi complex is disassembled from its pericen-
triolar disposition by a highly regulated course of mitotic
fragmentation involving mitogen-activated protein (MAP)
kinase and polo-like kinase pathways (Nelson, 2000; Ros-
sanese and Glick, 2001; Colanzi et al., 2003a,b; Ruan et al.,
2004; Xie et al., 2004), and they are subsequently further
vesiculated in a Cdc2-dependent manner (Lowe et al., 1998).
The dispersed Golgi membranes in hSac1-depleted cells bear
a superficial resemblance to those adopted by Golgi mem-
branes during a normal course of mitosis. One interpretation
of the data is that the Golgi dispersion phenotypes of hSac1-
deprived cells reflect a defect in progression though the cell
cycle, rather than a simple defect in Golgi organization per
se.
hSac1-deficient cells are competent to enter mitosis, but
they exhibit a high incidence of failure in properly organiz-
ing the mitotic spindle. These cells arrest in metaphase and
present both condensed chromatin and multiple mechani-
cally active spindles. The ectopic spindles are not the result
of derangements in centrosome duplication. The acentriolar
ectopic spindles nevertheless exert sufficient force to drive
aberrant segregation of chromosomal material. Such defects
in organization of mechanically active spindles likely result
in chromosomal nondisjunction events (Wong and Stearns,
2003), thereby defining an attractive mechanism for why
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mammalian cells deprived for Sac1 PIP phosphatase activity
fail to efficiently progress though G2/M and die. Several
aspects of the mitotic spindle phenotype recapitulate effects
seen when Golgi-associated protein GRASP-65 expression is
silenced in HeLa cells (Sütterlin et al., 2005). One major
distinction is that the multiple spindles of GRASP-65-defi-
cient mitotic cells are not mechanically active (Sütterlin et al.,
2005). Consistent with this distinction, GRASP-65 levels are
not reduced upon hSac1 deprivation (data not shown). Thus,
the mitotic defects associated with hSac1- and GRASP-65
depletion derive from what are apparently distinct mecha-
nisms.
The coincidence of Golgi and mitotic spindle structural
defects in hSac1- and GRASP-65–deprived cells reinforces
the intimate relationship between the Golgi apparatus and
control of spindle dynamics in higher eukaryotes. In partic-
ular, these findings support conclusions that the Golgi ap-
paratus and the centrosome are both spatially and function-
ally linked in mammalian cells (Sutterlin et al., 2005; Kodani
and Sutterlin, 2008; Lin et al., 2007). Those various observa-
tions raise the possibility of a causal relationship between
Golgi dysmorphology and the mitotic spindle defects that
accompany hSac1 depletion. In that regard, recent work
demonstrates TGN membranes have an intrinsic capability
to nucleate MTs (Efimov et al., 2007). Because the TGN seems
enriched in PtdIns-4-P, this raises the possibility that excess
PtdIns-4-P directly results in precocious nucleation of spin-
dle poles. Alternatively, Golgi membrane and mitotic spin-
dle organization may be confused in parallel by deranged
PIP pools that accumulate when Sac1 activity in the ER is
reduced below critical thresholds. Although we cannot yet
distinguish between these possibilities, both concepts raise
interesting possibilities regarding general principles for Sac1
function in mammalian cells. It is also worth emphasizing
that Golgi disorganization does not inevitably lead to defects
in spindle dynamics. Codepletion of Arf1 and Arf4 exerts
major defects in Golgi morphology without deranging the
organization of mitotic spindles.
A Role for Sac1 in Regulating Nuclear PIP Signaling?
Recent studies indicate Sac1 localization in mammalian cells
is influenced by growth factor status. That is, under condi-
tions of growth factor limitation, hSac1 is localized to Golgi
membranes, whereas it redistributes to the ER upon growth
factor resupply (Blagoveshchenskaya et al., 2008). These data
are consistent with hSac1 inhibiting membrane trafficking in
cells experiencing growth factor distress, and hSac1 relocal-
ization to the ER as release of the trafficking brake upon
growth factor supplementation (Blagoveshchenskaya et al.,
2008). Yet, in yeast (Rivas et al., 1999) and now in mammals,
it is essential that Sac1 PIP phosphatase activity be localized
to ER membranes for proper biological function. This is not
consistent with simple models where ER-localized Sac1 rep-
resents some inactive pool poised for activation upon redis-
tribution to the Golgi complex.
Why then is hSac1 residence in the ER of functional im-
portance? It is presently accepted that PIPs are not generated
in the ER and that no ER functions exhibit PIP dependence.
This requirement is made all the more curious by the fact
that ySac1 activity is, by all measure, dedicated to degrada-
tion of PtdIns-4-P generated specifically by the plasma mem-
brane Stt4 PtdIns 4-OH kinase (Nemoto et al., 2000; Foti et al.,
2001), although the possibility that plasma membrane/ER
contact sites may represent sites of functional interface be-
tween these enzymes cannot yet be excluded (Routt et al.,
2005). What functional rationale underlies such a paradoxi-
cal circuit? One idea is that PIP phosphatases function pri-
marily to degrade PIPs that occur in inappropriate compart-
ments. The net effect of such a “mop-up” activity is to
reinforce specific localization of PIP species so as to estab-
lish/maintain a “membrane PIP-code” that helps specify
organelle identity. In our view, this simplistic model does
not adequately account for cardinal properties of Sac1 PIP
phosphatase function. We find no evidence for wholesale
mislocalization of intracellular PIP-binding proteins in Sac1-
deficient HeLa cells. Moreover, a Sac1 involvement in
mop-up of mislocalized PIPs in ER membranes demands
effective PIP channeling to the ER for degradation. If PIPs
are rapidly mobilized between intracellular membranes in
vivo, such as is the case for phosphatidylserine (Wu et al.,
2000; Wu and Voelker, 2004), why would cells choose an
organelle with a large membrane surface (i.e., ER) for such
duty? A large membrane area will only dilute unrestricted
PIPs over its surface and reduce the efficiency with which
Sac1 consumes PIP substrates.
In our view, the available data are more consistent with
directed regulatory functions for Sac1 PIP phosphatases in
the ER, rather than with menial PIP-mop-up duties. What
might such regulatory functions be? We can only speculate
at this point. However, the ER is contiguous with the outer
nuclear envelope (Mattaj, 2004), and the nuclear matrix is a
physiologically significant site of PIP signaling (Irvine, 2002;
Cocco et al., 2004; Manzoli et al., 2005; Martelli et al., 2005;
Bunce et al., 2006). In that regard, the nuclear PIP 3-OH
kinase-C2 is activated during G2/M in human cells (Dobos
et al., 1993; Cappellini et al., 2003; Visnjic et al., 2003). The
continuity of the nuclear envelope with ER suggests Sac1
PIP phosphatases may reside in the ER to regulate nuclear
PIP signaling during the cell cycle. The derangements in
spindle organization associated with Sac1-deficiencies are
consistent such an involvement. To our knowledge, there are
(as yet) no functional data to link PIPs to activity of any
specific factor that participates in recruitment of -tubulin
ring complex ring complexes to centrosomes, or to any other
subunit of the spindle apparatus. Nonetheless, previous
studies reported that the nuclear PtdIns decrease by 50%,
and PtdIns-4-P and PtdIns-4,5-P2 levels decrease by 66%, in
S phase mammalian cells, even though bulk membrane Pt-
dIns and PIPs do not fluctuate so (York and Majerus, 1994).
These nuclear PIP dynamics are not only consistent with a
role for PIPs in regulating nuclear functions in a cell cycle-
dependent manner, but raise the question by what mecha-
nisms are nuclear PIP levels depressed during S phase. One
interesting possibility is a nuclear pool of the appropriate
PIP phosphatases oversees such a regulation. A second pos-
sibility is that PtdIns-4-P (or some 3-OH phosphorylated
PIP) is mobilized from the nuclear matrix/envelope to the
ER and subsequently degraded by Sac1. Perhaps Sac1 defi-
ciencies evoke derangements of nuclear PIPs, and these
derangements contribute to the formation of ectopic spindle
poles. Because the nuclear matrix seems incompetent for de
novo PtdIns synthesis (Rubbini et al., 1997; Martelli et al.,
2005), this scenario forecasts both exquisite control of PtdIns
import into the nuclear matrix and regulated degradation of
nuclear PIPs by enzymes other than phospholipases C.
Moreover, given the physiological coupling between ySac1
and the Stt4 PtdIns 4-OH kinase in yeast, it is of interest to
assess whether mammalian Sac1 also displays such a spe-
cific dedication to degradation of PIP produced by a specific
PtdIns (or PIP) kinase and, if so, which PtdIns kinase.
In summary, we demonstrate the Sac1 PIP phosphatase
executes essential housekeeping functions required for
proper Golgi and mitotic spindle organization in mammals.
We further show these essential functions require both PIP
Y. Liu et al.
Molecular Biology of the Cell3094
phosphatase activity and proper COP1-dependent retro-
grade trafficking of these enzymes so that Sac1 can be effi-
ciently retained in ER membranes. The cell cycle defects of
Sac1-deficient cells forecast these enzymes as underappreci-
ated, yet central integrators of PIP signaling in subcellular
compartments not normally considered as centers for intra-
cellular lipid signaling.
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